Sepsis studies

  • AM-Pharma

    Sepsis associated acute kidney injury.


    →The study and its progress
    Sepsis Current study
  • ASAHI KASEI

     Severe Sepsis  and coagulopathy


    →The study and its progress
    Sepsis, Coagulopathy Current study
  • SEPSIS-ACT

     Septic Shock


    →The study and its progress
    Sepsis Current study
  • ACCESS

    A controlled comparison of Eritoran Tetrasodium and placebo in patients with Severe Sepsis


    →The study and its progress
    Sepsis Terminated study
  • DiCD ( Disseminated Intravascular Coagulopathy Diagnosis )

    Study of hemostasis-inflammation interactions in septic shock.


    →The study and its progress
    Sepsis Terminated study
  • APROCCHS 2

    Phase III study comparing active Protein C, small doses of corticosteroids and their association in the treatment of shock septic.


    →The study and its progress
    Sepsis Terminated study
  • ADRENOSS

    Adrenomedullin and Outcome in Severe sepsis and Septic Shock (the ADRENOSS study)


    →The study and its progress
    Sepsis Terminated study
  • PROWESS SHOCK

    A randomized, double-blind, placebo-controlled, multicenter, Phase III study of drotrecogin alfa (activated) administered as a continuous 96-hour infusion to adult patient with septic shock.


    →The study and its progress
    Sepsis Terminated study
  • CytoFab™

     A multicenter,randomized,double-blind,placebo-controlled phase IIb study to compare the efficacy and safety of two dosing regimens of intravenous infusions of Cytofab (AZD9773) in adult patients with severe sepsis and/or septic shock.   


    →The study and its progress
    Sepsis Terminated study
  • IDEAL ICU

    Early Initiation of Dialysis at the Failure Stage Versus Deferred Dialysis in Intensive Care Unit Patients in Premature Phase of the Septic Shock Who Develop Acute Renal Insufficiency.
    I.D.E.A.L.-I.C.U. (Initiation of Dialysis EArly Versus Late in Intensive Care Unit)


    →The study and its progress
    Sepsis Terminated study
  • RESPOND

    A phase II study to evaluate dose and duration of treatment of Drotrecogin Alfa (Activated) using serial measurements of Protein C in patients with severe sepsis and multiple organ dysfunction.


    →The study and its progress
    Sepsis Terminated study
  • OASIS

    A phase II/III randomized, double-blind, placebo-controlled study of the safety and efficacy of Talactoferrin Alfa in patients with severe sepsis.


    →The study and its progress
    Sepsis Terminated study
  • SEPTIFLUX 2

    Prognostic Interest of Leucocyte Immunophenotyping Using Multiparameter 8-color Flow Cytometry During the Acute Phase of Sepsis.


    →The study and its progress
    Sepsis Terminated study